Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Goh, Wilson Wen Bin ^a,b   Fan, Mengyuan ^c   Low, Hong Sang ^d   Sergot, Marek ^a   Wong, Limsoon ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL RESEARCH FOUNDATION   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; COMPLEX FORMATION; DNA REPAIR; DNA REPLICATION; FALSE POSITIVE RESULT; G1 PHASE CELL CYCLE CHECKPOINT; GENE CLUSTER; GENE INTERACTION; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIVER CANCER; MALE; PROCESS DEVELOPMENT; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; PROTEOMICS SIGNATURE PROFILING; PURINE METABOLISM; RECOMBINATION REPAIR;

CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, GENETIC; LIVER NEOPLASMS; METABOLIC NETWORKS AND PATHWAYS; PROTEOMICS;

EID: 84872184001     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-35     Document Type: Article

References (21)

1. Goh WW, Lee YH, Chung M, Wong L. How advancement in biological network analysis methods empowers proteomics. Proteomics 2012, 12(4-5):550-563.
2. Goh WW, Lee YH, Ramdzan ZM, Sergot MJ, Chung M, Wong L. Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics. J Proteome Res 2012, 11(3):1571-1581. 10.1021/pr200698c, 3472506, 22243476.
3. Soh D, Dong D, Guo Y, Wong L. Consistency, comprehensiveness, and compatibility of pathway databases. BMC Bioinforma 2010, 11:449.
4. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002, 18(Suppl 1):S233-240. 10.1093/bioinformatics/18.suppl_1.S233, 12169552.
5. Rajagopalan D, Agarwal P. Inferring pathways from gene lists using a literature-derived network of biological relationships. Bioinformatics 2005, 21(6):788-793. 10.1093/bioinformatics/bti069, 15509611.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
7. Weber G. Enzymes of purine metabolism in cancer. Clin Biochem 1983, 16(1):57-63. 10.1016/S0009-9120(83)94432-6, 6861338.
8. Pang B, McFaline JL, Burgis NE, Dong M, Taghizadeh K, Sullivan MR, Elmquist CE, Cunningham RP, Dedon PC. Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA. Proc Natl Acad Sci USA 2012, 109(7):2319-2324. 10.1073/pnas.1118455109, 3289290, 22308425.
9. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005, 4(7):594-610. 10.1038/nrd1776, 16052242.
10. Jiang JT, Xu N, Zhang XY, Wu CP. Lipids changes in liver cancer. J Zhejiang Univ Sci B 2007, 8(6):398-409. 10.1631/jzus.2007.B0398, 1879165, 17565510.
11. Krynetski EY, Krynetskaia NF, Bianchi ME, Evans WE. A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res 2003, 63(1):100-106.
12. Goh WW, Lee YH, Zubaidah RM, Jin J, Dong D, Lin Q, Chung MC, Wong L. Network-based pipeline for analyzing MS data: an application toward liver cancer. J Proteome Res 2011, 10(5):2261-2272. 10.1021/pr1010845, 3256936, 21410269.
13. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 1989, 184(2):538-545. 10.1016/0014-4827(89)90352-2, 2806403.
14. Lotze MT, DeMarco RA. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs 2003, 4(12):1405-1409.
15. Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, Yanagawa N, Liu G, Jurisica I, Shepherd FA. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res 2011, 10(1):161-174. 10.1021/pr100491e, 20815376.
16. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R. The quantitative proteome of a human cell line. Mol Syst Biol 2011, 7:549. 3261713, 22068332.
17. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Paabo S, Mann M. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 2011, 7:548. 3261714, 22068331.
18. Kotera M, Hirakawa M, Tokimatsu T, Goto S, Kanehisa M. The KEGG databases and tools facilitating omics analysis: latest developments involving human diseases and pharmaceuticals. Methods Mol Biol 2012, 802:19-39. 10.1007/978-1-61779-400-1_2, 22130871.
19. Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, Evelo CT, Pico AR. WikiPathways: building research communities on biological pathways. Nucleic Acids Res 2012, 40:D1301-1307. 10.1093/nar/gkr1074, 3245032, 22096230.
20. Zhou X, Kao MC, Wong WH. Transitive functional annotation by shortest-path analysis of gene expression data. Proc Natl Acad Sci USA 2002, 99(20):12783-12788. 10.1073/pnas.192159399, 130537, 12196633.
21. Pavlidis P, Lewis DP, Noble WS. Exploring gene expression data with class scores. Pac Symp Biocomput 2002, 474-485. PMID 11928500.